i-SENS Inc (099190) - Cash Flow Conversion Efficiency

Latest as of March 2026: -0.004x

Based on the latest financial reports, i-SENS Inc (099190) has a cash flow conversion efficiency ratio of -0.004x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-1.56 Billion ≈ $-1.06 Million USD) by net assets (₩356.49 Billion ≈ $241.59 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market value of i-SENS Inc for the company's overall valuation and market capitalisation.

i-SENS Inc - Cash Flow Conversion Efficiency Trend (2012–2025)

This chart illustrates how i-SENS Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.

i-SENS Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of i-SENS Inc ranked by their cash flow conversion efficiency. Explore i-SENS Inc cash flow quality index to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
T&L Co. Ltd
KQ:340570
0.049x
Mycenax Biotech
TWO:4726
-0.031x
Alicanto Minerals Ltd
AU:AQI
-0.078x
Paxman AB
ST:PAX
-0.014x
Hope Education Group Co. Ltd
F:HE1
0.049x
Wanhwa Enterprise Co
TW:2701
0.006x
Seoul City Gas
KO:017390
-0.022x
Southern Petrochemicals Industries Corporation Limited
NSE:SPIC
0.592x

Annual Cash Flow Conversion Efficiency for i-SENS Inc (2012–2025)

The table below shows the annual cash flow conversion efficiency of i-SENS Inc from 2012 to 2025. View i-SENS Inc stock quote for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 ₩338.32 Billion
≈ $229.28 Million
₩20.12 Billion
≈ $13.63 Million
0.059x -11.16%
2024-12-31 ₩342.98 Billion
≈ $232.43 Million
₩22.96 Billion
≈ $15.56 Million
0.067x +55.73%
2023-12-31 ₩303.49 Billion
≈ $205.67 Million
₩13.05 Billion
≈ $8.84 Million
0.043x +84.64%
2022-12-31 ₩285.81 Billion
≈ $193.69 Million
₩6.65 Billion
≈ $4.51 Million
0.023x -63.73%
2021-12-31 ₩268.33 Billion
≈ $181.84 Million
₩17.22 Billion
≈ $11.67 Million
0.064x -59.30%
2020-12-31 ₩219.49 Billion
≈ $148.75 Million
₩34.61 Billion
≈ $23.46 Million
0.158x -17.49%
2019-12-31 ₩198.56 Billion
≈ $134.56 Million
₩37.95 Billion
≈ $25.72 Million
0.191x +76.94%
2018-12-31 ₩180.93 Billion
≈ $122.61 Million
₩19.54 Billion
≈ $13.24 Million
0.108x -21.41%
2017-12-31 ₩162.80 Billion
≈ $110.32 Million
₩22.38 Billion
≈ $15.16 Million
0.137x +75.44%
2016-12-31 ₩149.67 Billion
≈ $101.43 Million
₩11.73 Billion
≈ $7.95 Million
0.078x -54.15%
2015-12-31 ₩132.02 Billion
≈ $89.47 Million
₩22.56 Billion
≈ $15.29 Million
0.171x +13.76%
2014-12-31 ₩118.81 Billion
≈ $80.51 Million
₩17.85 Billion
≈ $12.09 Million
0.150x -3.22%
2013-12-31 ₩104.32 Billion
≈ $70.70 Million
₩16.19 Billion
≈ $10.97 Million
0.155x +108.16%
2012-12-31 ₩68.44 Billion
≈ $46.38 Million
₩5.10 Billion
≈ $3.46 Million
0.075x --

About i-SENS Inc

KQ:099190 Korea Healthcare Equipment & Supplies
Market Cap
$147.56 Million
₩217.73 Billion KRW
Market Cap Rank
#17814 Global
#749 in Korea
Share Price
₩15850.00
Change (1 day)
-0.38%
52-Week Range
₩14690.00 - ₩27000.00
All Time High
₩38452.83
About

i-SENS, Inc. provides diagnostic biosensors in South Korea. The company offers point of care testing devices, such as HbA1c, blood gas, electrolyte, and PT/INR analyzers; CareSens blood glucose monitoring systems; and lancing and other ancillary devices, as well as diabetes management services. It exports its products to approximately 110 countries, including the United States, Japan, and Europe.… Read more